As of 2025, the NIH has not approved ivermectin for treating COVID-19.

Here's the most up-to-date confirmation:
• The American Medical Association reiterated that the NIH’s COVID-19 Treatment Guidelines Panel continues to find insufficient evidence to recommend ivermectin for COVID-19.
• The FDA’s consumer update also remains firm: ivermectin is not authorized or approved for COVID-19 treatment.

What sparked confusion: Some social media posts misinterpreted NIH’s listing of ivermectin in clinical trial databases as a tacit endorsement. But inclusion in a trial registry does not equal approval—it simply means the drug is being studied.